Oncology

Filter

Monitoring and Managing Hyperglycemia in Breast Cancer Therapy

October 2026

From baseline glucose monitoring to first-line and second-line treatment, explore an illustrative patient example…

Monitoring and Managing Hyperglycemia in Breast Cancer Therapy

From baseline glucose monitoring to first-line and second-line treatment, explore an illustrative patient example…

Atypical EGFR NSCLC: An Unmet Need

Atypical EGFR mutations account for ~5–10% of EGFR mutations in NSCLC. See what community oncologists may be missing, from current options…

MATTERHORN: Survival Data in Resectable G/GEJ Cancer

Can the perioperative approach in resectable G/GEJ adenocarcinoma be improved? MATTERHORN, a global Phase III trial, evaluated…

First-line Advanced Biliary Tract Cancer: New Phase IIIb Data

TOURMALINE evaluated the safety and efficacy of first-line durvalumab combined with one of seven gemcitabine-based chemotherapy regimens…

Diarrhea Management in HER2-Mutant NSCLC

Oncology nurses support patients receiving targeted therapy by educating them on adverse event management. This infographic summarizes…

30 Apr 2026

Managing Adverse Events in HR+/HER2– Advanced Breast Cancer

Explore practical recommendations built to support patient counseling, monitoring, triage, management, and safe re-initiation…

Corrigendum: Monitoring and Managing Common Adverse Events with Capivasertib: Practical Steps for US Oncology Teams

This visual tool provides a team-based checklist plus grade-based pathways for prevention, monitoring, triage, escalation, and safe re-initiation.

Monitoring and Managing Common Adverse Events with Capivasertib

This visual tool provides a team-based checklist plus grade-based pathways for prevention, monitoring, triage, escalation, and safe re-initiation.

Loading posts...